Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b study of GB001 maintenance therapy in adults with moderate to severe eosinophilic asthma
2018-002242-36Phase 2Completed
- Sponsor
- Gossamer Bio
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in eosinophilic asthma (EA) and asthma comparing GB001 with Placebo (2 arms). Primary endpoint: Proportion of subjects with asthma worsening by Week 24. Started Sep 2018; status: completed.
02
Drugs
GB001
03
Conditions
eosinophilic asthma (EA)asthma
Beyond the preview
Go deeper on 2018-002242-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002242-36.